This drug is used in parts of Europe, Canada, and Japan, and it also inhibits ALDH via its active metabolite, nitroxyl (299). It has a shorter half-life than disulfiram but carries a higher risk of liver injury and is thus not frequently prescribed, and it is not US FDA-approved.